{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:19:26Z","timestamp":1788441566328,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.beem.2026.102109","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:12:38Z","timestamp":1777965158000},"page":"102109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and evaluation of sarcopenic obesity"],"prefix":"10.1016","volume":"40","author":[{"given":"Sanjay","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhur","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2026.102109_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.59556\/japi.73.1031","article-title":"Expert opinion on management advancements in sarcopenia: from muscle wasting to recovery","volume":"73","author":"Kalra","year":"2025","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.56543\/aaeeu.2025.4.3.02","article-title":"Understanding sarcopenia: the need for age-wise and disease-specific diagnostic criteria and comparison of existing diagnostic tools","volume":"4","author":"Bhandarkar","year":"2025","journal-title":"Anti-Aging East Eur"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nefro.2023.08.001","article-title":"Definition and evolution of the concept of sarcopenia","volume":"44","author":"Sanchez-Tocino","year":"2024","journal-title":"Nefrol (Engl Ed)"},{"issue":"2","key":"10.1016\/j.beem.2026.102109_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/ggi.14770","article-title":"Drug-related sarcopenia as a secondary sarcopenia","volume":"24","author":"Kuzuya","year":"2024","journal-title":"Geriatr & Gerontol Int"},{"key":"10.1016\/j.beem.2026.102109_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112924","article-title":"GLP-1 receptor agonists and sarcopenia: weight loss at a cost? A brief narrative review","volume":"229","author":"Pantazopoulos","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"2_","key":"10.1016\/j.beem.2026.102109_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.afos.2025.05.004","article-title":"Definition and diagnosis of sarcopenia: Asia-Pacific perspectives","volume":"11","author":"Huang","year":"2025","journal-title":"Osteoporos Sarcopenia"},{"issue":"5_","key":"10.1016\/j.beem.2026.102109_bib7","doi-asserted-by":"crossref","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.beem.2026.102109_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jfa.2017.30","article-title":"Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the international conference on frailty and sarcopenia research task force","volume":"7","author":"Vellas","year":"2018","journal-title":"J Frailty Aging"},{"issue":"8","key":"10.1016\/j.beem.2026.102109_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.beem.2026.102109_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\"","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr (Edinb Scotl)"},{"issue":"4","key":"10.1016\/j.beem.2026.102109_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"European working group on sarcopenia in older people. Sarcopenia: european consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.beem.2026.102109_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12603-021-1620-8","article-title":"Association between sarcopenia and fall risk according to the muscle mass adjustment method in Japanese older outpatients","volume":"25","author":"Kinoshita","year":"2021","journal-title":"J Nutr Health & Aging"},{"issue":"2","key":"10.1016\/j.beem.2026.102109_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.afos.2022.04.001","article-title":"South Asian working action group on SARCOpenia SWAG-SARCO) - a consensus document","volume":"8","author":"Dhar","year":"2022","journal-title":"Osteoporos Sarcopenia"},{"issue":"1","key":"10.1016\/j.beem.2026.102109_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Writing group for the European Working group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.beem.2026.102109_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working Group on Sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.beem.2026.102109_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","article-title":"Society on Sarcopenia, cachexia and wasting disorders trialist workshop. Sarcopenia with limited mobility: an international consensus","volume":"12","author":"Morley","year":"2011","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.beem.2026.102109_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"7","key":"10.1016\/j.beem.2026.102109_bib18","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jgs.16372","article-title":"Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium","volume":"68","author":"Bhasin","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.beem.2026.102109_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on Sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib21","doi-asserted-by":"crossref","first-page":"afae052","DOI":"10.1093\/ageing\/afae052","article-title":"Global leadership initiative in sarcopenia (GLIS) group. The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in Sarcopenia (GLIS)","volume":"53","author":"Kirk","year":"2024","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.beem.2026.102109_bib22","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/s43587-025-01004-y","article-title":"A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 consensus update","volume":"5","author":"Chen","year":"2025","journal-title":"Nat Aging"},{"issue":"4","key":"10.1016\/j.beem.2026.102109_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/aje\/kwh058","article-title":"Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women","volume":"159","author":"Janssen","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.beem.2026.102109_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1532-5415.2007.01140.x","article-title":"Health, aging and body composition study. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women","volume":"55","author":"Delmonico","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/nu16030436","article-title":"Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the up-to-date evidence","volume":"16","author":"Voulgaridou","year":"2024","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.beem.2026.102109_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041912","article-title":"New criteria of the Asian working group for sarcopenia: high prevalence of severe sarcopenia in hospitalized patients","volume":"104","author":"Han","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.beem.2026.102109_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2024.105596","article-title":"The evolving landscape of sarcopenia in Asia: a systematic review and meta-analysis following the 2019 Asian Working Group for Sarcopenia (AWGS) diagnostic criteria","volume":"128","author":"Weng","year":"2025","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"10.1016\/j.beem.2026.102109_bib28","first-page":"8","article-title":"The Indian sarcopenia staging system","volume":"35","author":"SCOPE Task Force","year":"2025","journal-title":"Indian J Clin Pract"},{"issue":"2_","key":"10.1016\/j.beem.2026.102109_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.afos.2025.06.003","article-title":"Epidemiology of sarcopenia: a narrative review","volume":"11","author":"Tseng","year":"2025","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.beem.2026.102109_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2024.105596","article-title":"The evolving landscape of sarcopenia in Asia: a systematic review and meta-analysis following the 2019 Asian Working Group for sarcopenia (AWGS) diagnostic criteria","volume":"128","author":"Weng","year":"2025","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"10.1016\/j.beem.2026.102109_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jdi.70185","article-title":"Prevalence and risk factors of sarcopenia in Asian adults with type 2 diabetes: a systematic review and meta-analysis","volume":"17","author":"Wu","year":"2026","journal-title":"J Diabetes Investig"},{"issue":"1","key":"10.1016\/j.beem.2026.102109_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40842-024-00179-4","article-title":"Unraveling the enigma of sarcopenia and sarcopenic obesity in Indian adults with type 2 diabetes - a comparative cross-sectional study","volume":"10","author":"Yogesh","year":"2024","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2026.102109_bib33","doi-asserted-by":"crossref","first-page":"725e36","DOI":"10.1007\/s41999-020-00332-z","article-title":"Diagnostic cut-offs, prevalence, and biochemical predictors of sarcopenia in healthy Indian adults: the Sarcopenia-Chandigarh Urban Bone Epidemiological Study (Sarco-CUBES)","volume":"11","author":"Pal","year":"2020","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"10.1016\/j.beem.2026.102109_bib34","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jgs.19373","article-title":"Prevalence and determinants of sarcopenia among older adults in India: insights from the Longitudinal Aging Study in India","volume":"73","author":"Rao","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.beem.2026.102109_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100375","article-title":"Obesity: prevalence, causes, consequences, management, preventive strategies and future research directions","volume":"27","author":"Ahmed","year":"2025","journal-title":"Metab Open"},{"key":"10.1016\/j.beem.2026.102109_bib36","article-title":"The global burden of overweight-obesity and its association with economic status, benefiting from STEPs survey of WHO member states: a meta-analysis","volume":"46","author":"Islam","year":"2024","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.beem.2026.102109_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4178121","article-title":"Defining and diagnosing obesity in India: a call for advocacy and action","volume":"2023","author":"Kalra","year":"2023","journal-title":"J Obes"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4158\/EP161688.PS","article-title":"Adiposity-based chronic disease as a new diagnostic term: the American Association of Clinical Endocrinologists and American College of endocrinology position statement","volume":"23","author":"Mechanick","year":"2017","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"Reviewers of the AACE\/ACE obesity clinical practice guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.beem.2026.102109_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.beem.2026.102109_bib41","first-page":"163","article-title":"Consensus Group. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.beem.2026.102109_bib42","article-title":"Assessment of obesity in the Indian setting: a clinical review","volume":"23","author":"Sruthia","year":"2023","journal-title":"Clin Epidemiol Glob Health"},{"issue":"11","key":"10.1016\/j.beem.2026.102109_bib43","first-page":"2337","article-title":"Sarcopenic obesity: anthropometric diagnosis","volume":"72","author":"Kalra","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.beem.2026.102109_bib44","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.clnu.2021.01.005","article-title":"Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: The lifelines cohort study","volume":"40","author":"Wagenaar","year":"2021","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.beem.2026.102109_bib45","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1016\/j.clnu.2021.06.009","article-title":"Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis","volume":"40","author":"Gao","year":"2021","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.beem.2026.102109_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13534","article-title":"Deciphering the \"obesity paradox\" in the elderly: a systematic review and meta-analysis of sarcopenic obesity","volume":"24","author":"Liu","year":"2023","journal-title":"Obes Rev"},{"issue":"6","key":"10.1016\/j.beem.2026.102109_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/17843286.2025.2583187","article-title":"Prevalence, diagnosis and treatment of sarcopenic obesity in older adults: a systematic review and a meta-analysis","volume":"80","author":"\u015eeng\u00fcl Ay\u00e7i\u00e7ek","year":"2025","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.beem.2026.102109_bib48","article-title":"Sarcopenic obesity: a review","volume":"68","author":"Borba","year":"2025","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib49","first-page":"361","article-title":"Sarcopenic obesity definitions and their associations with physical frailty in older Brazilian adults: data from the SARCOS study","volume":"67","author":"Frisoli","year":"2023","journal-title":"Arch Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2026.102109_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102109_bib51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12603-009-0084-z","article-title":"Sarcopenic-obesity and cardiovascular disease risk in the elderly","volume":"13","author":"Stephen","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.beem.2026.102109_bib52","doi-asserted-by":"crossref","DOI":"10.4103\/singaporemedj.SMJ-2024-233","article-title":"Sarcopenia and sarcopenic obesity in cardiovascular disease: a comprehensive review","author":"Tan","year":"2025","journal-title":"Singap Med J"},{"issue":"1","key":"10.1016\/j.beem.2026.102109_bib53","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/eurheartjsupp\/suae100","article-title":"Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score","volume":"27","author":"Panattoni","year":"2025","journal-title":"Eur Heart J Suppl"},{"issue":"5","key":"10.1016\/j.beem.2026.102109_bib54","doi-asserted-by":"crossref","first-page":"392","DOI":"10.12809\/hkmj219411","article-title":"Frailty and sarcopenia\u2014from theory to practice","volume":"28","author":"Luk","year":"2022","journal-title":"Hong Kong Med J"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.orcp.2025.05.001","article-title":"The Asia-Oceania consensus: definitions and diagnostic criteria for sarcopenic obesity","volume":"19","author":"Chen","year":"2025","journal-title":"Obes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.beem.2026.102109_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2600031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2600031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:38:39Z","timestamp":1783381119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X2600031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1521690X2600031X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102109","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and evaluation of sarcopenic obesity","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102109"}}